Interleukin-6 in clinical medicine
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411–1416
Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL-6 and related molecules. FASEB J 4: 2860–2867
Andus T, Gross V, Cäsar J, Krumm D, Hosp J, David M, Schölmerich J (1991) Activation of monocytes during inflammatory bowel disease. Pathobiol (in press)
Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimoto T, Takaku F, Akiyama Y (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of plate-lets. Blood 75: 1602–1605
Asaoku H, Kawano M, Iwato K, Tanabe O, Tanaka H, Hirano T, Kishimoto T, Kuramoto A (1988) Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma. Blood 72: 429–432
Bataille R, Jourdan M, Zhang XG, Klein B (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest 84: 2008–2010
Bauer J (1989) Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth. Klin Wochenschr 67: 697–706
Bauer J, Ganter U, Geiger T, Jacobshagen U, Hirano T, Matsuda T, Kishimoto T, Andus T, Acs G, Gerok W, Ciliberto G (1988) Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 72: 1134–1140
Bauer J, Bauer TM, Kalb T, Taga T, Lengyel G, Hirano T, Kishimoto T, Acs G, Mayer L, Gerok W (1989) Regulation of interleukin-6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med 170: 1537–1549
Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauweriins J, Greiling H, Heinrich PC (1990) Interleukin-1 β induces synthesis and secreation of interleukin-6 in human chondrocytes. FEBS Lett 263: 321–324
Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivels M, Steinmann RM, Sehgal PB, May LT (1989) IL-6/IFNβ2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. J Immunol 143: 2153–2159
Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A (1989) Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73: 1279–1284
Bodine D, Karlsson S, Nienhuis AW (1989) Combination of interleukin-3 and -6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hemopoietic stem cells. Proc Natl Acad Sci USA 86: 8897–8901
Bot FJ, van Eijk L, Broeders L, Aarden LA, Löwenberg B (1989) Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. Blood 73: 135–137
Brach MA, Löwenberg B, Mantovani L, Schwulera U, Brennscheidt U, Mertelsmann R, Herrmann F (1990) Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts. Blood 76: 1972–1979
Brach MA, Cicco NA, Riedel D, Hirano T, Kishimoto T, Mertelsmann RH, Herrmann F (1990) Mechanisms of differential regulation of interleukin-6 mRNA accumulation by tumor necrosis factor alpha and lymphotoxin during monocytic differentiation. FEBS Lett 263: 349–354
Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW (1990) Dysregulated interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86: 592–599
Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O (1990) Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144: 480–484
Broukaert P, Spriggs DR, Demetri G, Kufe DW, Fiers W (1989) Circulating interleukin-6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med 169: 2257–2262
Caracciolo D, Clark SC, Rovera G (1989) Human interleukin-6 supports granulocyte differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood 73: 666–670
Chen L, Novick D, Rubinstein M, Revel M (1988) Recombinant interferon-β2 (interleukin-6) induces myeloid differentiation. FEBS Lett 239: 299–304
Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon β2. Proc Natl Acad Sci USA 85: 8037–8041
Chiu CP, Lee F (1989) IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. J Immunol 142: 1909–1915
Cicco NA, Lindemann A, Content J, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F (1989) Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 75: 2049–2052
Everson MP, Brown CB, Lilly MB (1989) Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells. Blood 74: 1472–1476
Fiedler W, Weh HJ, Sucin E, Wittlief C, Stocking C, Hossfeld DK (1990) The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma. Leukemia 4: 462–465
Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF (1989) Endotoxemia elicits increased circulating IFN-β2/IL-6 in man. J Immunol 142: 2321–2324
Freeman GJ, Freedman AS, Rabinowe SN, Segil JM, Horowitz J, Rosen K, Whitman JF, Nadler LM (1989) Interleukin-6 gene expression in normal and neoplastic B cells. J Clin Invest 83: 1512–1518
Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin-6 in the central nervous system in viral disease. Eur J Immunol 19: 689–694
Ganter U, Arcone R, Toniatti C, Ciliberto G (1989) Dual control of CRP gene expression by interleukin-1 and interleukin-6. EMBO J 8: 3773–3779
Garman RD, Jacobs KA, Clark SC, Raulet DH (1987) B-cellstimulatory factor 2 (β2-interferon) functions as a second signal for interleukin-2 production by mature murine T cells. Proc Natl Acad Sci USA 84: 7629–7633
Grau GE (1990) Implications of cytokines in immunopathology: experimental and clinical data. Eur Cytokine Net 1: 203–210
Grossmann RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371
Guerne PA, Carson DA, Lotz M (1990) IL-6 production by human articular chondrocytes. J Immunol 144: 499–505
Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJM, Eerenberg-Belmer AJM, Thijs LG, Aarden LA (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710
Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB (1989) Multiple forms of IFN-β2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142: 948–953
Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (1990) Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 63: 1149–1157
Hill RJ, Warren MK, Levin J (1990) Stimulation of thrombopoiesis in mice by human recombinant interleukin-6. J Clin Invest 85: 1242–1247
Hirano T (1990) Interleukin-6 in immune response and hematopoiesis. In: Mertelsmann R, Herrmann F (eds) Hematopoietic growth factors in clinical applications. Marcel Dekker, New York, pp 471–488
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSF-2). Proc Natl Acad Sci USA 82: 5490–5494
Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B-cell differentiation factor defined by antipeptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84: 228–231
Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T (1988) Excessive production of interleukin-6/B-cell-stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797–1801
Hoang T, Haman A, Goncalves O, Wong GG, Clark SC (1988) Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 72: 823–826
Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fuji Y, Dohi K, Ishikawa H, Ohomoto Y, Yoshizaki K, Hirano T, Kishimoto T (1989) Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143: 3949–3955
Houssiau FA, Bukasa K, Sindic CJM, Van Damme J, Van Snick J (1988) Elevated levels of the 26-K human hybridoma growth factor (interleukin-6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 71: 320–323
Houssiau FA, Coulie PG, Olive D, Van Snick J (1988) Synergistic activation of human T cells by interleukin-1 and interleukin-6. Eur J Immunol 18: 653–656
Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035–9039
Ishibashi T (1989) Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA (1989) Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86: 5953–5957
Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989) Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244
Ishikawa H, Tanaka H, Iwato K, Tanabe O, Assaoku H, Nobuyoshi M, Yamamoto I, Kawano M, Kuramoto A (1990) Effect of glucocorticoids on the biological activities of myeloma cells: inhibition of interleukin-1β osteoclast activating factorinduced bone resorption. Blood 75: 715–720
Ishimi Y, Miyaura L, Jin C, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145: 3297–3303
Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT (1989) IL-6/IFNβ2 as a circulating hormone. Induction by cytokine administration. J Immunol 142: 1542–1547
Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B (1990) Constitutive production of interleukin-6 and immunologic features in cardiac myxoma. Arthritis Rheum 33: 398–403
Kato K, Yokoi T, Takano N, Kanegane H, Yachie A, Miyawaki T, Taniguchi N (1990) Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol 144: 1317–1322
Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85
Kirnbauer R, Köck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA (1989) IFNβ2, BSF-2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142: 1922–1928
Klein B, Zhang XG, Jourdan M, Content J, Houssian F, Aarden L, Piechaczyk M, Bataille R (1989) Paracrine rather than autocrine regulation of myeloma — cell growth and differentiation by IL-6. Blood 73: 517–526
Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R (1990) Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Net 1: 193–201
Klein H, Becher R, Lübbert M, Oster W, Schleiermacher E, Brach MA, Souza L, Lindemann A, Mertelsmann R, Herrmann F (1990) Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia. J Exp Med 171: 1785–1790
Koike K, Nakahata T, Kikuchi T, Takagi M, Ishiguro A, Tsuji K, Naganuma K, Okano A, Akiyama T (1990) Interleukin-6 enhances murine megakaryocytopoiesis in serum-free culture. Blood 75: 2286–2291
Krutman J, Elmets CA (1988) Recent studies on mechanisms in photoimmunology. Photochem Photobiol 48: 787–798
Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD (1990) IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144: 4226–4230
Lansdorp PM, Aarden LA, Calafat J, Zeiljemaker WP (1986) A growth-factor-dependent B-cell hybridoma. Curr Top Microbiol Immunol 132: 105–113
Lee JD, Swisher SG, Minehart EH, Mc Bride WH, Economou JS (1990) Interleukin-4 down regulates interleukin-6 production in human peripheral blood mononuclear cells. J Leuk Biol 47: 475–479
Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC, Ogawa M (1988) Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha. Blood 71: 1759–1763
Lindemann A, Ganser A, Hoelzer D, Mertelsmann R, Herrmann F (1991) In vivo administration of recombinant human interleukin-3 elicits an acute phase response involving endogenous synthesis of interleukin-6. Ann Intern Med (in press)
Loppnow H, Libby P (1990) Proliferating or interleukin-1-activated human vascular smooth muscle cells screte copious interleukin-6. J Clin Invest 85: 731–738
Lotem J, Shabo Y, Sachs L (1989) Regulation of megakaryocyte development by interleukin-6. Blood 74: 1545–1551
Lorre K, Van Damme J, Verwilghen J, Baroja ML, Ceuppens JL (1990) IL-6 is an accessory signal in the alternative CD2-mediated pathway of T-cell activation. J Immunol 144: 4681–4687
Lübbert M, Oster W, McComick F, Mertelsmann R, Herrmann F (1991) Clonal analysis of N-ras gene activation in acute myeloid leukemia. J Clin Invest (in press)
Lübbert M, Brach M, Mertelsmann R, Herrmann F (1991) Interleukin-6 inhibits growth of plasma cell neoplasms due to suppression of endogenous interleukin-6. Blood (in press)
Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Kock A, Urbanski A, Borth W, Schauer E (1989) Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells: regulation of the acute phase and immune responses. Ann NY Acad Sci 557: 405–414
Luger TA, Krutman J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Köck A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB (1989) IFNβ2/IL-6 augments the activity of human natural killer cells. J Immunol 143: 1206–1209
Mantovani L, Henschler R, Brach MA, Wieser R, Lübbert M, Lindemann A, Mertelsmann R, Herrmann F (1990) Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin. FEBS Lett 270: 152–156
Matsuda T, Hirano T, Kishimoto T (1988) Establishment of a interleukin-6 dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur J Immunol 18: 951–956
Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T (1989) Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal carcinomas. FEBS Lett 250: 607–610
Miles SA, Rezai AR, Salazar-Gonzales JF, Van der Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O (1990) AIDS Kaposi sarcomaderived cells produce and respond to interleukin-6. Proc Natl Acad Sci USA 87: 4068–4072
Morinaga Y, Suzuki H, Takatsuki F, Akiyama Y, Taniyama T, Matsushima K, Onozaki K (1989) Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J Immunol 143: 3538–3542
Moshage HJ, Roelofs HNJ, Van Pelt JF, Hazenberg BPC, Van Leewen MA, Limburg PC, Aarden LA, Yap SH (1988) The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Comm 155: 112–117
Mule JJ, McIntosh JK, Jablons DM, Rosenberg SA (1990) Antitumor activity of recombinant interleukin-6 in mice. J Exp Med 171: 629–636
Musso T, Espinoza-Delgado J, Pulkki K, Gussela GL, Longo DL, Varesio L (1990) Transforming growth factor beta downregulates interleukin-1-induced IL-6 production by human monocytes. Blood 76: 2466–2469
Nagasawa T, Orita T, Matsushita J, Tsuchiya M, Neichi T, Imazeki I, Imai N, Ochi N, Kanma H, Abe T (1990) Thrombopoietic activity of human interleukin-6. FEBS Lett 260: 176–178
Nijsten MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet 2: 921
Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann R, Herrmann F (1989) Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 84: 451–457
Poli G, Bressler P, Kinter T, Duh E, Timmer WC, Rabson A, Justement S, Stanley S, Fauci AS (1990) Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and posttranscriptional mechanisms. J Exp Med 172: 151–158
Pullicino EA, Carli F, Poole S, Rafferty B, Malik STA, Elia M (1990) The relationship between the circulating concentrations of interleukin-6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphok Res 9: 2–6
Rennick D, Jackson J, Yang G, Wideman J, Lee F, Hudak S (1989) Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythoid, myeloid and multipotential progenitor cells. Blood 73: 1828–1835
Revel M, Chen L, Novivk D, Shulman LM, Gotthelf Y, Cohen B, Raber J, Chebath J, Michaelevicz R (1990) The growthpromoting, differentiative and cytostatic properties of interleukin-6. Proc Am Assoc Canc Res 31: 499–505
Romero R, Avila C, Santhanam U, Sehgal PB (1990) Amniotic fluid interleukin-6 in preterm labor. J Clin Invest 85: 1392–1400
Rose-John S, Schooltink H, Lenz D, Hipp E, Dufhues G, Schmitz H, Schiel X, Hirano T, Kishimoto T, Heinrich PC (1990) Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem 190: 79–83
Sachs L, Lotem J, Shabo Y (1989) The molecular regulators of macrophage and granulocyte development. Ann NY Acad Sci 557: 417–437
Shabo Y, Lotem J, Sachs L (1989) Autoregulation of interleukin-6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemia cells. Mol Cell Biol 9: 4109–4112
Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJG, Van Damme J (1989) The serum interleukin-6 response to elective surgery. Lymphok Res 8: 123–127
Siegall CB, Chaudhary VK, Fitzgerald DJ, Pastan I (1988) Cytotoxic activity of an interleukin-6-Pseudomonas exotoxin fusion protein on human myeloma cells. Proc Natl Acad Sci USA 85: 9738–9742
Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi J, Van Damma E, Mantovani A (1989) IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142: 549–553
Smyth MJ, Ortaldo JR, Bere W, Yagita H, Okumura K, Young HA (1990) IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 145: 1159–1166
Suzuki C, Okano A, Takatsuki F, Miyasaka Y, Hirano T, Kishimoto T, Ejima D, Akiyama Y (1989) Continuous perfusion with interleukin-6 enhances production of hematopoietic stem cells (CFU-S). Biochem Biophys Res Commun 159: 933–938
Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauweriins J, Greiling H, Heinrich PC (1990) Interleukin-1 β induces synthesis and secreation of interleukin-6 in human chondrocytes. FEBS Lett 263: 321–324
Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB (1991) Interleukin-6 immunoreactivity in human tumors. Am J -Pathol (in press)
Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB (1989) Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma. J Exp Med 170: 1649–1669
Te Velde AA, Huijbens RJF, Heije K, des Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor-alpha and IL-6 by monocytes. Blood 76: 1392–1397
Tosato G, Miller J, Marti G, Pike SE (1990) Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4-positive lymphocytes. Blood 75: 922–930
Utsumi K, Takai Y, Tada T, Ohzeki S, Fujiwara H, Hamaoka T (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol 145: 397–403
van der Schoot CE, Jansen P, Poorter M, Wester MR, Kr. von dem Borne AEG, Aarden LA, von Oers RHJ (1989) Interleukin-6 and interleukin-1 production in acute myeloid leukemia with monocytoid differentiation. Blood 74: 2081–2087
van Oers MHJ, van der Heyden AAPAM, Aarden LA (1988) Interleukin-6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 71: 314–319
van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9684
Yasukawa K, Hirano T, Watanabe Y, Murutoni K, Matsuda T, Nakai S, Kishimoto T (1987) Structure and expression of human B-cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 6: 2939–2945
Yoshizaki K, Nakagawa T, Fukunaga K, Tseng LT, Yamamura Y, Kishimoto T (1984) Isolation and characterization of B-cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J Immunol 132: 2948–2954
Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahate T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto S (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74: 1360–1367